Medtronic Plc (NYSE: MDT) on Friday, plunged -0.89% from the previous trading day, before settling in for the closing price of $90.82. Within the past 52 weeks, MDT’s price has moved between $75.96 and $93.08.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 1.24%. The company achieved an average annual earnings per share of 4.83%. With a float of $1.27 billion, this company’s outstanding shares have now reached $1.28 billion.
Let’s determine the extent of company efficiency that accounts for 95000 employees. In terms of profitability, gross margin is 62.65%, operating margin of 17.83%, and the pretax margin is 15.62%.
Medtronic Plc (MDT) Insider Activity
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Medtronic Plc is 0.11%, while institutional ownership is 84.75%. The most recent insider transaction that took place on Jan 24 ’25, was worth 1,119,330. In this transaction EVP & Pres Neuroscience of this company sold 12,437 shares at a rate of $90.00, taking the stock ownership to the 40,979 shares. Before that another transaction happened on Jan 24 ’25, when Company’s Officer proposed sale 12,437 for $90.00, making the entire transaction worth $1,119,330.
Medtronic Plc (MDT) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.61 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 4.83% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.58% during the next five years compared to -4.12% drop over the previous five years of trading.
Medtronic Plc (NYSE: MDT) Trading Performance Indicators
Medtronic Plc (MDT) is currently performing well based on its current performance indicators. A quick ratio of 1.39 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.50. Likewise, its price to free cash flow for the trailing twelve months is 20.99.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 3.28, a number that is poised to hit 1.36 in the next quarter and is forecasted to reach 5.84 in one year’s time.
Technical Analysis of Medtronic Plc (MDT)
Looking closely at Medtronic Plc (NYSE: MDT), its last 5-days average volume was 5.41 million, which is a drop from its year-to-date volume of 7.28 million. As of the previous 9 days, the stock’s Stochastic %D was 42.73%. Additionally, its Average True Range was 1.55.
During the past 100 days, Medtronic Plc’s (MDT) raw stochastic average was set at 77.74%, which indicates a significant increase from 45.76% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 16.58% in the past 14 days, which was lower than the 18.45% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $85.09, while its 200-day Moving Average is $84.77. However, in the short run, Medtronic Plc’s stock first resistance to watch stands at $90.94. Second resistance stands at $91.86. The third major resistance level sits at $92.56. If the price goes on to break the first support level at $89.32, it is likely to go to the next support level at $88.62. Should the price break the second support level, the third support level stands at $87.70.
Medtronic Plc (NYSE: MDT) Key Stats
Market capitalization of the company is 115.42 billion based on 1,282,286K outstanding shares. Right now, sales total 32,364 M and income totals 3,677 M. The company made 8,403 M in profit during its latest quarter, and 1,269 M in sales during its previous quarter.
